Nuveen Asset Management, LLC Heron Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,106,696 shares of HRTX stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,106,696

Previous 1,180,228 6.23%

Holding current value

$1.35 Million

Previous $4.13 Million 46.68%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.73 - $3.67 $127,210 - $269,862	-73,532 Reduced 6.23%	1,106,696 $2.2 Million
Q2 2024 Aug 09, 2024	BUY	$2.32 - $3.86 $198,455 - $330,188	85,541 Added 7.81%	1,180,228 $4.13 Million
Q1 2024 May 13, 2024	BUY	$1.71 - $3.06 $1.72 Million - $3.07 Million	1,002,935 Added 1093.09%	1,094,687 $3.03 Million
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $698,499 - $1.81 Million	-629,279 Reduced 87.27%	91,752 $106,000
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $659,139 - $1.42 Million	436,516 Added 153.42%	721,031 $1.09 Million
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $6,221 - $12,912	-2,765 Reduced 0.96%	284,515 $712,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $1,699 - $3,431	-639 Reduced 0.22%	287,280 $1.21 Million
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $623,651 - $1.71 Million	-271,153 Reduced 48.5%	287,919 $804,000
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $749,120 - $1.61 Million	-161,797 Reduced 22.44%	559,072 $2.86 Million
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $234,142 - $353,316	-28,041 Reduced 3.74%	720,869 $6.1 Million
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $763,832 - $1.13 Million	-75,403 Reduced 9.15%	748,910 $9.06 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $4.43 Million - $6.17 Million	333,667 Added 68.01%	824,313 $12.8 Million
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $668,148 - $955,419	46,111 Added 10.37%	490,646 $7.95 Million
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $4.64 Million - $7.04 Million	-317,830 Reduced 41.69%	444,535 $9.41 Million
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $1.67 Million - $2.17 Million	-121,985 Reduced 13.79%	762,365 $11.3 Million
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $509,826 - $1.01 Million	46,816 Added 5.59%	884,350 $13 Million
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $1.3 Million - $3.11 Million	126,654 Added 17.82%	837,534 $9.83 Million
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $5.64 Million - $8.61 Million	323,639 Added 83.58%	710,880 $16.7 Million
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $26,077 - $34,095	1,594 Added 0.41%	387,241 $7.16 Million
Q2 2019 Aug 15, 2019	BUY	$16.93 - $26.22 $6.53 Million - $10.1 Million	385,647 New	385,647 $7.17 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $145M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Heron Therapeutics, Inc. Transaction History